Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript - Thomson StreetEvents

Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript

Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript - Thomson StreetEvents
Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript
Published Oct 29, 2021
Published Oct 29, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of REDY.NS earnings conference call or presentation 29-Oct-21 12:00pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Dr Reddy's Laboratories Ltd
Ticker
REDY.NS
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Shrikant Akolkar - Asian Markets Securities Private Limited, Research Division - Analyst : My first question is on Revlimid in Canada. So can you please talk about initial trends like price erosion or market share gain? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. OCTOBER 29, 2021 / 12:00PM, REDY.NS - Q2 2022 Dr Reddy's Laboratories Ltd Earnings Call

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Yes. 2 questions. One, in terms of the outlook in terms of biosimilars. When do you see it contributing meaningfully? And I mean, by which year? And secondly, in the -- during the quarter, there has been some license fee income as well as some -- as well as sale of price income. So adjusted for that, how much would be the normalized EBITDA margin led Dr. Reddy's Labs on?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Okay. About your partnership with Fresenius Kabi?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : For pegfilgrastim?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Okay. But they have got the approval, right? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. OCTOBER 29, 2021 / 12:00PM, REDY.NS - Q2 2022 Dr Reddy's Laboratories Ltd Earnings Call

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Okay. Yes. And regarding the EBITDA margin?

Table Of Contents

Dr Reddy's Laboratories Ltd Q2 2023 Earnings Call Transcript – 2022-10-28 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 28-Oct-22 1:00pm GMT

Dr Reddy's Laboratories Ltd Q1 2023 Earnings Call Transcript – 2022-07-28 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 28-Jul-22 1:00pm GMT

Dr Reddy's Laboratories Ltd Investor Day Transcript – 2022-06-21 – US$ 54.00 – Edited Transcript of REDY.NS corporate analyst meeting</ 21-Jun-22 11:30am GMT

Dr Reddy's Laboratories Ltd Q4 2022 Earnings Call Transcript – 2022-05-19 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 19-May-22 12:00pm GMT

Dr Reddy's Laboratories Ltd Q3 2022 Earnings Call Transcript – 2022-01-28 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 28-Jan-22 1:00pm GMT

Dr Reddy's Laboratories Ltd Q1 2022 Earnings Call Transcript – 2021-07-27 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 27-Jul-21 12:00pm GMT

Dr.Reddy's Laboratories Ltd Q4 2021 Earnings Call Transcript – 2021-05-14 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 14-May-21 12:00pm GMT

Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript – 2021-01-29 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 29-Jan-21 12:00pm GMT

Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-13 – US$ 54.00 – Edited Transcript of REDY.NS presentation 13-Jan-21 4:00pm GMT

Dr.Reddy's Laboratories Ltd Q2 2021 Earnings Call Transcript – 2020-10-28 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 28-Oct-20 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript" Oct 29, 2021. Alacra Store. May 02, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2022-Dr-Reddy-s-Laboratories-Ltd-Earnings-Call-T15002989>
  
APA:
Thomson StreetEvents. (2021). Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript Oct 29, 2021. New York, NY: Alacra Store. Retrieved May 02, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2022-Dr-Reddy-s-Laboratories-Ltd-Earnings-Call-T15002989>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.